← Leaderboards
Sonia Leach
National Jewish Health
$1,607,855
Attributed
$6,431,419
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,431,419 · 2
By mechanism
R01$6,431,419 · 2
Top collaborators
- Nabeel Hamzeh4 shared
- Laura L Koth4 shared
- Brian P O'Connor4 shared
- Maneesh Bhargava3 shared
- Elliott D Crouser3 shared
- Lisa A Maier3 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Lisa A Maier$11,952,941
- Donna L Bratton$11,834,515
- Nabeel Hamzeh$3,068,174
- Ivana V Yang$13,155,768
- Peter M Henson$23,575,855
Others in their field
Other Emerging Leaders on “Prospective”
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$31,845,607
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
ProspectivePathway InteractionsPhenotypeProgressive DiseaseMortalityOutcome PredictionDisease ProgressionFutureInflammationGenetic TranscriptionMolecularMorbidity - Disease RateBloodBioinformaticsAffectCohortEnrollmentFollow-UpGenesGranulomatousCellsCharacteristicsLungPulmonary Sarcoidosis
Grant awards (7)
Molecular Characterization of Progressive Pulmonary Sarcoidosis$784,774
R01 · FY2025 · HL
Molecular Characterization of Progressive Pulmonary Sarcoidosis$772,729
R01 · FY2024 · HL
Molecular Characterization of Progressive Pulmonary Sarcoidosis$826,678
R01 · FY2023 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$992,527
R01 · FY2021 · HL · contact PI
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$999,912
R01 · FY2020 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$1,004,873
R01 · FY2019 · HL
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis$1,049,926
R01 · FY2018 · HL